...
首页> 外文期刊>Zeitschrift fur Anorganische und Allgemeine Chemie >Influence of Halogen Substitution in the Ligand Sphere on the Antitumor and Antibacterial Activity of Half-sandwich Ruthenium(II) Complexes [RuX((6)-arene)(C5H4N-2-CH=N-Ar)](+)
【24h】

Influence of Halogen Substitution in the Ligand Sphere on the Antitumor and Antibacterial Activity of Half-sandwich Ruthenium(II) Complexes [RuX((6)-arene)(C5H4N-2-CH=N-Ar)](+)

机译:半夹心钌(II)络合物抗肿瘤和抗菌活性卤素取代对半夹心钌(II)络合物的影响[Rux((6) - 酮)(C5H4N-2-CH = N-Ar)](+)

获取原文
获取原文并翻译 | 示例
           

摘要

New complexes [((6)-p-cymene)Ru(C5H4N-2-CH=N-Ar)X]PF6 [X = Br (1), I (2); Ar = 4-fluorophenyl (a), 4-chlorophenyl (b), 4-bromophenyl (c), 4-iodophenyl (d), 2,5-dichlorophenyl (e)] were prepared, as well as 3a-3e (X = Cl) and the new complexes [((6)-arene)RuCl(N-N)]PF6 (arene = C6H5OCH2CH2OH, N-N = 2,2-bipyridine (4), 2,6-(dimethylphenyl)-pyridin-2-yl-methylene amine (5), 2,6-(diisopropylphenyl)-pyridin-2-yl-methylene amine (6); arene = p-cymene, N-N = 4-(aminophenyl)-pyridin-2-yl-methylene amine (7)]. X-ray diffraction studies were performed for 1a, 1b, 1c, 1d, 2b, 5, and 7. Cytotoxicities of 1a-1d and 2 were established versus human cancer cells epithelial colorectal adenocarcinoma (Caco-2) (IC50: 35.8-631.0 M), breast adenocarcinoma (MCF7) (IC50: 36.3-128.8.0 M), and hepatocellular carcinoma (HepG2) (IC50: 60.6-439.8 M), 3a-3e were tested against HepG2 and Caco-2, and 4-7 were tested against Caco-2. 1-7 were tested against non-cancerous human epithelial kidney cells. 1 and 2 were more selective towards tumor cells than the anticancer drug 5-fluorouracil (5-FU), but 3a-3e (X = Cl) were not selective. 1 and 2 had good activity against MCF7, some with lower IC50 than 5-FU. Complexes with X = Br or I had moderate activity against Caco-2 and HepG2, but those with Cl were inactive. Antibacterial activities of 1a, 2b, 3a, and 7 were tested against antibacterial susceptible and resistant Gram-negative and -positive bacteria. 1a, 2b, and 3a showed activity against methicillin-resistant S. aureus (MIC = 31-2000 gmL(-1)).
机译:新络合物[((6)-p-cymene)ru(c5h4n-2-ch = n-ar)x] pf6 [x = br(1),i(2);制备4-氟苯基(A),制备4-氯苯基(B),4-溴苯基(C),4-碘苯基(D),2,5-二氯苯基(E)],以及3A-3E(x = Cl)和新配合物[((6) - 砷)RuCl(NN)] PF6(Arene = C6H5OCH2CH2OH,NN = 2,2-吡啶(4),2,6-(二甲基苯基) - 吡啶-2-基 - 亚甲基胺(5),2,6-(二异丙基苯基) - 吡啶-2-基 - 亚 - 亚甲基胺(6);芳烃= P-Cymene,NN = 4-(氨基苯基) - 吡啶-2-基 - 亚甲基胺( 7)。进行X射线衍射研究,对1A,1B,1C,1D,2B,5和7进行。1A-1D和2的细胞毒性与人癌细胞上皮结直肠癌(CACO-2)(IC50 :35.8-631.0 m),乳腺腺癌(MCF7)(IC50:36.3-128.8.0 m)和肝细胞癌(Hepg2)(IC50:60.6-439.8 m),对Hepg2和Caco-2进行3A-3E, 4-7针对Caco-2测试。对非癌性人的上皮肾细胞测试1-7。1和2对肿瘤细胞比抗癌药物5-氟尿嘧啶更具选择性(5 -fu),但3a-3e(x = cl)没有选择性。 1和2对MCF7有良好的活动,其中一些具有较低的IC50比5-FU。 X = Br的复合物或我对Caco-2和Hepg2进行了适度的活性,但有CL的那些是无活性的。测试1A,2B,3A和7的抗菌活性,用于针对抗菌易感和抗性革兰氏阴性和阳性细菌进行测试。参照图1A,2B和3A对耐甲氧西林的S.UUREUS(MIC = 31-2000 GML(-1))进行活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号